Thioridazine
Back to searchMolecule Structure
Scientific Name
Thioridazine
Description of the Drug
Thioridazine is a phenothiazine antipsychotic used to treat schizophrenia and generalized anxiety disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00679
http://www.drugbank.ca/drugs/DB00679
Brand Name(s)
Mellaril, Mellaril-s, Melleril, Rideril
Company Owner(s)
Fosun Pharma Usa Inc, Watson Laboratories Inc, Novartis Pharmaceuticals Corp, Par Pharmaceutical Inc, West Ward Pharmaceutical Corp, Roxane Laboratories Inc, Actavis Mid Atlantic Llc, Ani Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Sandoz Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Serotonin 2c (5-HT2c) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL225 |
| D2-like dopamine receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL2331075 |
| Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Clinical Trial(s)
Unichem Links
| Atlas | thioridazine | |
| SureChEMBL | SCHEMBL9566 | |
| PharmGKB | PA451666 | |
| Human Metabolome Database | HMDB0014817 | |
| WDI | THIORIDAZ | |
| DrugBank | DB00679 | |
| PubChem: Thomson Pharma | 14804036 | |
| PubChem | 5452 | |
| Mcule | MCULE-7796139302 | |
| LINCS | LSM-1863 | |
| Nikkaji | J4.104A | |
| BindingDB | 50002338 | |
| EPA CompTox Dashboard | DTXSID6023656 | |
| DrugCentral | 2637 | |
| Brenda | 6096 | |
| ChemicalBook | CB6763367 | |
| Guide to Pharmacology | 100 | |
| GSRS | bd2f1773-53b8-48b7-bef9-6122206267f3 | |
| rxnorm | THIORIDAZINE | THIORIDAZINE HYDROCHLORIDE |
| PubChem: Drugs of the Future | 12013415 | |
| ChEBI | 9566 |
